Vertex swung to a second-quarter loss of $961,000, or 1 cent a share, compared with a profit of $5.2 million, or 3 cents a share. Adjusted per-share earnings were 15 cents, beating analyst ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880.

Get the latest Vertex Pharmaceuticals Incorporated (VRTX) stock news and headlines to help you in your trading and investing decisions.

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

Hang Seng Index | historical charts for HSI to see performance over time with comparisons to other stock exchanges.

The best power banks and portable chargers for every device in 2025 Never run out of juice again, no matter where you are with these best portable battery chargers.